High Phenolic Extra Virgin Olive Oil ( DrugBank: Olive oil, Olive )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 13 | Multiple sclerosis/Neuromyelitis optica | 1 |
13. Multiple sclerosis/Neuromyelitis optica
Clinical trials : 3,342 / Drugs : 2,355 - (DrugBank : 406) / Drug target genes : 269 - Drug target pathways : 241
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04787497 (ClinicalTrials.gov) | December 2021 | 1/3/2021 | The Effect of Extra Virgin Olive Oil in People With Multiple Sclerosis | The Neuropsychological Effects of Extra-Virgin Olive Oil in People With Multiple Sclerosis | Multiple Sclerosis | Dietary Supplement: High Phenolic Extra Virgin Olive Oil | University of Cyprus | World Olive Center for Health;Ellis-Farm, Eliama Daily Value | Not yet recruiting | 18 Years | 65 Years | All | 100 | N/A | NULL |